BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 12734395)

  • 21. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells.
    Clarkin CE; Emery RJ; Pitsillides AA; Wheeler-Jones CP
    J Cell Physiol; 2008 Feb; 214(2):537-44. PubMed ID: 17685428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation.
    Zhang G; Zhou J; Fan Q; Zheng Z; Zhang F; Liu X; Hu S
    FEBS Lett; 2008 Aug; 582(19):2957-64. PubMed ID: 18671974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation.
    Bruhl T; Urbich C; Aicher D; Acker-Palmer A; Zeiher AM; Dimmeler S
    Circ Res; 2004 Apr; 94(6):743-51. PubMed ID: 14764452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
    Bai J; Wang YJ; Liu L; Zhao YL
    J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases.
    Umeda N; Ozaki H; Hayashi H; Oshima K
    Am J Ophthalmol; 2004 Aug; 138(2):270-9. PubMed ID: 15289137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
    Groppa E; Brkic S; Uccelli A; Wirth G; Korpisalo-Pirinen P; Filippova M; Dasen B; Sacchi V; Muraro MG; Trani M; Reginato S; Gianni-Barrera R; Ylä-Herttuala S; Banfi A
    EMBO Rep; 2018 May; 19(5):. PubMed ID: 29643120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of EphB4/EphrinB2 reverse signal on angiogenesis induced by Xuefu Zhuyu Capsule () containing serum in human microvascular endothelial cell 1.
    Zhang JS; Wang YZ; Hu YQ; Lin F; Gao D; Song J; Kaptchuk TJ; Chen KJ
    Chin J Integr Med; 2016 Aug; 22(8):605-10. PubMed ID: 27299459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries.
    Katsuta H; Fukushima Y; Maruyama K; Hirashima M; Nishida K; Nishikawa S; Uemura A
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4102-8. PubMed ID: 23696610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo.
    Philippova M; Banfi A; Ivanov D; Gianni-Barrera R; Allenspach R; Erne P; Resink T
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2222-30. PubMed ID: 16873731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
    Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
    Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2.
    Zisch AH; Zeisberger SM; Ehrbar M; Djonov V; Weber CC; Ziemiecki A; Pasquale EB; Hubbell JA
    Biomaterials; 2004 Jul; 25(16):3245-57. PubMed ID: 14980419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spheroid-based engineering of a human vasculature in mice.
    Alajati A; Laib AM; Weber H; Boos AM; Bartol A; Ikenberg K; Korff T; Zentgraf H; Obodozie C; Graeser R; Christian S; Finkenzeller G; Stark GB; Héroult M; Augustin HG
    Nat Methods; 2008 May; 5(5):439-45. PubMed ID: 18391960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: potential role in the angiogenic response.
    Boguslawski G; Grogg JR; Welch Z; Ciechanowicz S; Sliva D; Kovala AT; McGlynn P; Brindley DN; Rhoades RA; English D
    Exp Cell Res; 2002 Apr; 274(2):264-74. PubMed ID: 11900487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells.
    Wirz W; Antoine M; Tag CG; Gressner AM; Korff T; Hellerbrand C; Kiefer P
    Differentiation; 2008 Sep; 76(7):784-94. PubMed ID: 18177423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.
    Zhao C; Irie N; Takada Y; Shimoda K; Miyamoto T; Nishiwaki T; Suda T; Matsuo K
    Cell Metab; 2006 Aug; 4(2):111-21. PubMed ID: 16890539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
    Sturz A; Bader B; Thierauch KH; Glienke J
    Biochem Biophys Res Commun; 2004 Jan; 313(1):80-8. PubMed ID: 14672701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis.
    Scott AN; Hetheridge C; Reynolds AR; Nayak V; Hodivala-Dilke K; Mellor H
    Angiogenesis; 2008; 11(4):337-46. PubMed ID: 18758974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.